Search research articles
Contact Us
Filters
Showing results (131-140 of 143) with videos related to
Page
of 15
Sort By:
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
|
January 24, 2023
Epinephrine iontophoresis attenuates changes in skin blood flow and abolishes cutaneous contamination of near-infrared diffuse correlation spectroscopy estimations of muscle perfusion
Miles F Bartlett, Alberto Palmero-Canton, Andrew P Oneglia, et al.
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons
|
August 28, 2023
Proceedings of the Third American Association of Oral and Maxillofacial Surgeons Anesthesia Patient Safety Conference
Deepak G Krishnan, Mary A Schnitzer, Edward C Adlesic, et al.
The Journal of Bone and Joint Surgery. American Volume
|
June 16, 2001
Prevention of venous thromboembolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin
R H Fitzgerald, T E Spiro, A A Trowbridge, et al.
The Journal of Bone and Joint Surgery. American Volume
|
January 1, 1994
Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety. Enoxaparin Clinical Trial Group
C W Colwell, T E Spiro, A A Trowbridge, et al.
Archives of Internal Medicine
|
February 10, 1997
Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. An economic perspective
R D Hull, G E Raskob, G F Pineo, et al.
Archives of Internal Medicine
|
February 10, 1997
Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs intravenous heparin. An economic perspective
R D Hull, G E Raskob, D Rosenbloom, et al.
The New England Journal of Medicine
|
April 9, 1992
Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis
R D Hull, G E Raskob, G F Pineo, et al.
Texas Medicine
|
September 1, 1987
Hematology-oncology. Hematology-Oncology Workgroup, Legislative Task Force on Cancer in Texas
F H Gardner, J B Alperin, J A Belli, et al.
Annals of Internal Medicine
|
February 15, 2001
Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease
G Merli, T E Spiro, C G Olsson, et al.
Frontiers in Cellular and Infection Microbiology
|
July 13, 2023
Prevalence and antibiotic resistance of <i>Staphylococcus aureus</i> associated with a college-aged cohort: life-style factors that contribute to nasal carriage
Sean T Congdon, John A Guaglione, Omario M A Ricketts, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 143) with videos related to
Sort By:
Page
of 15
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
|
January 24, 2023
Epinephrine iontophoresis attenuates changes in skin blood flow and abolishes cutaneous contamination of near-infrared diffuse correlation spectroscopy estimations of muscle perfusion
Miles F Bartlett, Alberto Palmero-Canton, Andrew P Oneglia, et al.
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons
|
August 28, 2023
Proceedings of the Third American Association of Oral and Maxillofacial Surgeons Anesthesia Patient Safety Conference
Deepak G Krishnan, Mary A Schnitzer, Edward C Adlesic, et al.
The Journal of Bone and Joint Surgery. American Volume
|
June 16, 2001
Prevention of venous thromboembolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin
R H Fitzgerald, T E Spiro, A A Trowbridge, et al.
The Journal of Bone and Joint Surgery. American Volume
|
January 1, 1994
Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety. Enoxaparin Clinical Trial Group
C W Colwell, T E Spiro, A A Trowbridge, et al.
Archives of Internal Medicine
|
February 10, 1997
Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. An economic perspective
R D Hull, G E Raskob, G F Pineo, et al.
Archives of Internal Medicine
|
February 10, 1997
Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs intravenous heparin. An economic perspective
R D Hull, G E Raskob, D Rosenbloom, et al.
The New England Journal of Medicine
|
April 9, 1992
Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis
R D Hull, G E Raskob, G F Pineo, et al.
Texas Medicine
|
September 1, 1987
Hematology-oncology. Hematology-Oncology Workgroup, Legislative Task Force on Cancer in Texas
F H Gardner, J B Alperin, J A Belli, et al.
Annals of Internal Medicine
|
February 15, 2001
Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease
G Merli, T E Spiro, C G Olsson, et al.
Frontiers in Cellular and Infection Microbiology
|
July 13, 2023
Prevalence and antibiotic resistance of <i>Staphylococcus aureus</i> associated with a college-aged cohort: life-style factors that contribute to nasal carriage
Sean T Congdon, John A Guaglione, Omario M A Ricketts, et al.
Page
of 15